ABSI Absci Corp

USD 4.6900 0.01 (+0.21%)
Icon

Absci Corp (ABSI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 4.69

0.00 (0.00)%

USD 0.44B

0.87M

USD 4.75(+1.28%)

USD 12.67 (+170.15%)

Icon

ABSI

Absci Corp (USD)
COMMON STOCK | NSD
USD 4.6900
0.01 (+0.21%)
At close: 04:00PM EST
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 0.44B

USD 12.67 (+170.15%)

USD 4.69

Absci Corp (ABSI) Stock Forecast

Show ratings and price targets of :
USD 4.75
(+1.28%)

Based on the Absci Corp stock forecast from 3 analysts, the average analyst target price for Absci Corp is USD 4.75 over the next 12 months. Absci Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Absci Corp is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Absci Corp’s stock price was USD 4.69. Absci Corp’s stock price has changed by -12.01% over the past week, +33.24% over the past month and +109.38% over the last year.

No recent analyst target price found for Absci Corp
No recent average analyst rating found for Absci Corp

Company Overview Absci Corp

Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington. Addr...Read More

https://www.absci.com

18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683

193

December

USD

USA

Adjusted Closing Price for Absci Corp (ABSI)

Loading...

Unadjusted Closing Price for Absci Corp (ABSI)

Loading...

Share Trading Volume for Absci Corp Shares

Loading...

Compare Performance of Absci Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ABSI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Absci Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD90.49B 26.38 17.57

ETFs Containing ABSI

Symbol Name ABSI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Absci Corp (ABSI) Stock

Based on ratings from 3 analysts Absci Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on ABSI's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for ABSI is USD 4.75 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 3.

Unfortunately we do not have enough data on ABSI's stock to indicate if its overvalued.

The last closing price of ABSI's stock was USD 4.69.

The most recent market capitalization for ABSI is USD 0.44B.

Based on targets from 3 analysts, the average taret price for ABSI is projected at USD 4.75 over the next 12 months. This means that ABSI's stock price may go up by +1.28% over the next 12 months.

We can't find any ETFs which contains Absci Corp's stock.

As per our most recent records Absci Corp has 193 Employees.

Absci Corp's registered address is 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683. You can get more information about it from Absci Corp's website at https://www.absci.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...